Sanobiotec is a visionary brand dedicated to researching and developing minor cannabinoids for a wide range of wellness applications. With a passionate and persistent team, this Lithuania-based startup began its journey in 2018 with the goal of helping others overcome illnesses such as cancer, insomnia, arthritis, epilepsy, obesity, and more. Recognizing the potential of cannabinoids in addressing these health issues, Sanobiotec started as a research facility and quickly gained trust from local institutions.

Today, Sanobiotec offers a diverse range of products and services. They are a global bulk ingredient manufacturer, specializing in isolates, oils, and liquids. Their portfolio includes sought-after minor cannabinoids like CBN, CBC, CBDV, CBGA, and CBDA isolates, as well as mainstream natural CBD and CBG isolates.

With decades of experience, they provide copious amounts of natural and (semi) synthetic compounds with the highest purity. Quality is at the core of Sanobiotec's values. They adhere to European Pharmacopeia and ISO standards, ensuring transparency, traceability, and top-notch quality in their production process.

Through partnerships with national and educational institutions, they push the boundaries of cannabinoid research and development. Join Sanobiotec on their journey to deliver premium-quality cannabinoid products and explore the potential benefits of these compounds for holistic well-being